Peptonic Medical Stock Return On Equity
28L Stock | 0.0002 0.00 0.00% |
PEPTONIC MEDICAL fundamentals help investors to digest information that contributes to PEPTONIC MEDICAL's financial success or failures. It also enables traders to predict the movement of PEPTONIC Stock. The fundamental analysis module provides a way to measure PEPTONIC MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PEPTONIC MEDICAL stock.
PEPTONIC |
PEPTONIC MEDICAL Company Return On Equity Analysis
PEPTONIC MEDICAL's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PEPTONIC MEDICAL Return On Equity | -1.14 |
Most of PEPTONIC MEDICAL's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PEPTONIC MEDICAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, PEPTONIC MEDICAL has a Return On Equity of -1.1384. This is much lower than that of the sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The return on equity for all Germany stocks is notably higher than that of the company.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
PEPTONIC Fundamentals
Return On Equity | -1.14 | |||
Return On Asset | -0.52 | |||
Profit Margin | (1.88) % | |||
Shares Outstanding | 396.79 M | |||
Gross Profit | 19.07 M | |||
Book Value Per Share | 0.72 X | |||
Earnings Per Share | (0.19) X | |||
Beta | 0.58 | |||
Market Capitalization | 3.77 M |
About PEPTONIC MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PEPTONIC MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PEPTONIC MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PEPTONIC MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PEPTONIC Stock
PEPTONIC MEDICAL financial ratios help investors to determine whether PEPTONIC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PEPTONIC with respect to the benefits of owning PEPTONIC MEDICAL security.